| Susan Mcmullen Jager, NP | |
|
8510 Bryant St Ste 200, Westminster, CO 80031-3845 | |
| (303) 650-4460 | |
| (720) 565-4128 |
| Full Name | Susan Mcmullen Jager |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 8510 Bryant St Ste 200, Westminster, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134117583 | NPI | - | NPPES |
| 10823271 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | APN.0002692-NP (Colorado) | Primary |
| Entity Name | Clinica Campesina Family Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225025406 PECOS PAC ID: 7315850484 Enrollment ID: O20031106000276 |
News Archive
In an aggressive disease known for poor response rates, researchers from The University of Texas MD Anderson Cancer Center found patients with advanced colorectal cancer responded well to a combination therapy of the drugs vermurafenib, cetuximab and irinotecan.
Virginia Commonwealth University physicists, working with one of the most precious materials on Earth – gold - and with one of the most common – sand - have created a so-called "nano-bullet" that targets tumors and may help scientists develop non-invasive cancer treatments.
Three-dimensional tattoos offer a new alternative for creating a natural-looking nipple after breast reconstruction.
Zogenix, Inc. today announced completion of enrollment in its open-label Phase 3 safety study (Study 802) of ZX002. ZX002 is a novel, oral, single-entity, controlled-release formulation of hydrocodone for the treatment of moderate to severe pain in patients requiring around-the-clock opioid therapy for an extended period of time.
OXiGENE, a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced that an ongoing analysis of positive results reported earlier from a randomized, controlled, Phase 2/3 study of ZYBRESTAT (fosbretabulin, CA4P) were presented today at the 35th European Society of Medical Oncology (ESMO) Congress in Milan, Italy by Julie Ann Sosa, M.D., F.A.C.S., of Yale University.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Susan Mcmullen Jager, NP 1735 S Public Rd Ste 203, Lafayette, CO 80026-7093 Ph: (303) 665-3036 | Susan Mcmullen Jager, NP 8510 Bryant St Ste 200, Westminster, CO 80031-3845 Ph: (303) 650-4460 |
News Archive
In an aggressive disease known for poor response rates, researchers from The University of Texas MD Anderson Cancer Center found patients with advanced colorectal cancer responded well to a combination therapy of the drugs vermurafenib, cetuximab and irinotecan.
Virginia Commonwealth University physicists, working with one of the most precious materials on Earth – gold - and with one of the most common – sand - have created a so-called "nano-bullet" that targets tumors and may help scientists develop non-invasive cancer treatments.
Three-dimensional tattoos offer a new alternative for creating a natural-looking nipple after breast reconstruction.
Zogenix, Inc. today announced completion of enrollment in its open-label Phase 3 safety study (Study 802) of ZX002. ZX002 is a novel, oral, single-entity, controlled-release formulation of hydrocodone for the treatment of moderate to severe pain in patients requiring around-the-clock opioid therapy for an extended period of time.
OXiGENE, a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced that an ongoing analysis of positive results reported earlier from a randomized, controlled, Phase 2/3 study of ZYBRESTAT (fosbretabulin, CA4P) were presented today at the 35th European Society of Medical Oncology (ESMO) Congress in Milan, Italy by Julie Ann Sosa, M.D., F.A.C.S., of Yale University.
› Verified 9 days ago
Mrs. Onna Klooster, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8510 Bryant St, 200, Westminster, CO 80031 Phone: 303-430-5560 Fax: 303-430-5565 | |
Ms. Mara Talin Minasian, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8300 Alcott St Ste 101, Westminster, CO 80031 Phone: 970-806-3695 | |
Tricia Lea Vath, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 8510 Bryant St Ste 350, Westminster, CO 80031 Phone: 303-430-2640 Fax: 303-430-2625 | |
Rubi Dominguez Rakel, AGACNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 14300 Orchard Pkwy, Westminster, CO 80023 Phone: 720-627-3761 Fax: 720-627-3758 | |
Leslie Marie Kennedy, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8510 Bryant St Ste 200, Westminster, CO 80031 Phone: 303-650-4460 Fax: 720-565-4130 | |
Courtney Williams, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 12061 Tejon St Ste 600, Westminster, CO 80234 Phone: 303-457-0123 Fax: 303-252-4065 |